Sarah Bock is a partner in Goodwin’s ERISA & Executive Compensation practice. Sarah advises both private and public companies, with a focus on clients in the life sciences, technology and private equity sectors.
Experience
Sarah advises clients on the design, drafting and administration of equity-based compensation programs, employment, severance, change in control and deferred compensation arrangements, including associated tax (including Section 409A), accounting and securities law implications. She also assists public companies with corporate compensation disclosure for proxy filings and other applicable securities filings. Sarah also plays an active role in corporate transactions, representing both buyers and sellers in connection with employee benefits and compensation-related aspects of transactions, including pre-signing negotiations, executive and equity compensation (including Section 280G – the golden parachute rules) and in post-closing employee integration matters.
Representative Matters
- Dynatrace in its $620 million initial public offering
- Phreesia in its $140.6 million initial public offering
- Carbon Black in its $152 million initial public offering
- Neon Therapeutics in its $100 million initial public offering
- resTORbio in its $85 million initial public offering
- Xeris Pharmaceuticals in its $98 million initial public offering
- Scholar Rock in its $86 million initial public offering
- Ra Pharmaceuticals in its $58 million public follow-on offering
- Allena Pharmaceuticals in its $75 million initial public offering
- Deciphera Pharmaceuticals in its $127.5 million initial public offering
- CRISPR Therapeutics AG in its $56 million initial public offering
- BeiGene in it its $158 million initial public offering
- AquaVenture Holdings in its $117 million initial public offering
- Carbon Black in its $2.1 billion sale to VMWare
- Qualtrics in its $8 billion sale to SAP
- SimpliSafe in its sale to Hellman & Friedman
- 6 River Systems on its $450 million sale to Shopify
- Semma Therapeutics in its $950 million sale to Vertex
- Pillpack in its sale to Amazon
- Aspire Health in its sale to Anthem
- Sqrrl Data in its sale to Amazon
- Guidewire in its $275 million acquisition of Cyence
- Ocera Therapeutics, in its sale to Mallinckrodt for up to $117 million in upfront cash and contingent (CVR) consideration
- Merchants Bancshares, Inc. in its sale to Community Bank System, Inc.
- automotiveMastermind in its partial sale to IHS Markit Ltd. for $392 million
- Agility Fuel Systems in its merger with the CNG Automotive Products Division of Hexagon Composites to form Agility Fuel Solutions
- Onyx in its $10 billion sale to Amgen
- Truck Hero, Inc. in connection with its sale to CCMP
- ANSYS in numerous acquisition transactions
Areas of Practice
Professional Activities
Sarah is a member of the Boston Bar Association and American Bar Association.
Credentials
Education
JD2006
Boston College
(cum laude)
BA2003
Northwestern University
(magna cum laude)
Admissions
Bars
- Massachusetts
Recognition & Awards
Sarah has been recognized multiple times by Legal 500 US for her work in employee benefits and executive compensation and retirement plans: transactional. In 2024, she was named a Recommended Lawyer by the Legal 500 US.